These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6037 related articles for article (PubMed ID: 1805572)

  • 1. Preparation and characterization of antisera and of murine monoclonal antibodies to human glioma-associated antigen(s).
    Matsuda M; Fischer DK; Narayan RK; Atassi MZ
    Adv Exp Med Biol; 1991; 303():271-83. PubMed ID: 1805572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paucity of humoral response in patients to glioma-associated antigen(s): antigen localization by immunofluorescence.
    Fischer DK; Matsuda M; Shaban F; Narayan RK; Atassi MZ
    Adv Exp Med Biol; 1991; 303():263-70. PubMed ID: 1805570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous demonstration of glia- and glioma-associated antigens in human astrocytomas.
    Bilzer T; Martin B; Stavrou D; Keiditsch E
    Int J Cancer Suppl; 1988; 2():41-4. PubMed ID: 3162445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human glioma-specific antigens detected by monoclonal antibodies.
    Kondo S; Miyatake S; Iwasaki K; Oda Y; Kikuchi H; Zu Y; Shamoto M; Namba Y
    Neurosurgery; 1992 Apr; 30(4):506-11. PubMed ID: 1584348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro efficacy of anti-glial fibrillary acidic protein monoclonal antibodies against human malignant glioma cell lines.
    Abaza MS; Narayan RK; Atassi MZ
    Jpn J Cancer Res; 1997 Nov; 88(11):1094-9. PubMed ID: 9439685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human glioma associated intermediate filament proteins: over-expression, co-localization and cross-reactivity.
    Abaza MS; Shaban F; Narayan RK; Atassi MZ
    Anticancer Res; 1998; 18(2B):1333-40. PubMed ID: 9615812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies reactive with glioma cell lines derived from experimental brain tumors.
    Stavrou D; Süss C; Bilzer T; Kummer U; De Tribolet N
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1439-49. PubMed ID: 6196200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of monoclonal antibodies in the diagnosis and treatment of primary brain tumors.
    Bullard DE; Bigner DD
    J Neurosurg; 1985 Jul; 63(1):2-16. PubMed ID: 2409248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted transport of 125I-labeled antibody to GFAP and AMVB1 in an experimental rat model of C6 glioma.
    Chekhonin VP; Baklaushev VP; Yusubalieva GM; Gurina OI
    J Neuroimmune Pharmacol; 2009 Mar; 4(1):28-34. PubMed ID: 18770045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies in neuro-oncology.
    Stavrou D
    Neurosurg Rev; 1990; 13(1):7-18. PubMed ID: 2181345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies against human solid tumors.
    Burtin P; Nardelli J
    Bull Cancer; 1983; 70(2):108-12. PubMed ID: 6191805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of a brain tumor-selective monoclonal antibody from hybridoma between mouse myeloma and rat spleen cells immune to syngeneic glioma.
    Saya H; Masuko T; Hashimoto Y
    Jpn J Cancer Res; 1985 Dec; 76(12):1198-202. PubMed ID: 3937832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune response in melanoma and glioma patients: a solubilized melanoma-membrane component as a tool for detecting circulating antibodies.
    Birkmayer GD
    Cancer; 1981 Dec; 48(11):2399-408. PubMed ID: 7296490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of monoclonal and polyclonal antibodies against human alphafetoprotein, a hepatocellular tumor marker.
    Chou SF; Hsu WL; Hwang JM; Chen CY
    Hybrid Hybridomics; 2002 Aug; 21(4):301-5. PubMed ID: 12193284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of three restricted specificity monoclonal antibodies raised against the human glioma cell line D-54 MG.
    Wikstrand CJ; Bigner SH; Bigner DD
    J Neuroimmunol; 1984 Jun; 6(3):169-86. PubMed ID: 6373821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies against human astrocytomas and their reactivity pattern.
    Stavrou D; Keiditsch E; Schmidberger F; Bise K; Funke I; Eisenmenger W; Kurrle R; Martin B; Stocker U
    J Neurol Sci; 1987 Sep; 80(2-3):205-20. PubMed ID: 3316507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a monoclonal antibody recognizing a 138 kDa glioblastoma-associated antigen.
    Klaich GM; Kanter PM
    Anticancer Drugs; 1995 Feb; 6(1):45-52. PubMed ID: 7756683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies reactive with epitopes restricted to glial fibrillary acidic proteins of several species.
    Pegram CN; Eng LF; Wikstrand CJ; McComb RD; Lee YL; Bigner DD
    Neurochem Pathol; 1985; 3(2):119-38. PubMed ID: 2413405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibodies to glial fibrillary antigen as potential carriers of drugs for glial tumors].
    Obukhov SK; Kalashnikova VV; Khalanskiĭ AS
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (2):30-2. PubMed ID: 2787569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen variation in a human glioblastoma: from the primary tumor to the second recurrence, permanent cell line and xenotransplantation tumors.
    Bilzer T; Stavrou D; Wechsler W; Wöhler B; Keiditsch E
    Anticancer Res; 1991; 11(2):547-53. PubMed ID: 2064311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 302.